Inflarx Pharmaceuticals, INC.
Pharmaceutical company.
Based in MI
🤖
AI Overview
With $50K in lobbying spend across 10 quarterly filings, Inflarx Pharmaceuticals, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2023 to 2025.
$50K
Total Spend
3
Years Active
1
Firms Hired
2
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2023 | $40K |
| 2024 | $10K |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Inflarx Pharmaceuticals, INC. disclosed contacting in their lobbying filings.
Natl Institutes of Health (NIH)SENATE
View all agency pressure data →What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
NIH panel review of GOHIBIC.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.